This website uses cookies to enhance the user experience.
21st logo
||
B

BLOSTRUPMOEN NORGE AS918 399 046

Purchase and sale
Limited company
Kolonivegen 2072 DAL, Norge

BLOSTRUPMOEN NORGE AS

Operating
Salg og utleie av hjertestartere og kursing innenfor førstehjelp, salg av produkter innenfor førstehjelp/legemidler.
Salg av tjenester og produkter innen legemidler, samt investering og deltakelse i annen forretningsvirksomhet, herunder deltakelse i andre selskaper, samt hva hermed står i forbindelse.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
SB

Stian Botten Olsen1973

Chairman of the board
LH

Lars Håkon Blostrupmoen1974

Years since formation
9 years
since Jan 19, 2017
Type
Limited company
VAT registered
Yes
Number of employees
25

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2025
37,005,761
NOK
Annual total result 2025
3,081,322
NOK
Last update: Jul 30, 2026

Management

Management / administration

NameRoleShares
SB

Stian Botten Olsen

1973

Managing Director/CEO-

Board

NameRoleShares
LH

Lars Håkon Blostrupmoen

1974

Chairman
94.44 %
indirectly
GM

Gunn Marit Stenvoll

1972

Board Member-
HG

Hans Georg Selmer

1969

Board Member
5.56 %
indirectly
SO

Sigbjørn Olav Ringvold

1950

Board Member-
SB

Stian Botten Olsen

1973

Board Member-

Others

NameRoleShares
M
MYRDAHL OG SVEEN AS
Auditor-

Top 10 individual shareholders

NameRoleShares
LH

Lars Håkon Blostrupmoen

1974

Chairman
94.44 %
indirectly
HG

Hans Georg Selmer

1969

Board Member
5.56 %
indirectly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
S
SKOGEN GROUP AS
Ordinary shares
30,000
100 %
Last update: Jun 2, 2025

Group structure

  • SKOGEN GROUP AS
    Total operating income 2025: NOK 1,063,002
    Operating profit 2025: NOK -2,922,230
    Employees: 0

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
37,005,761
33,684,256
30,969,913
29,648,534
25,275,735
Annual Total Result
3,081,322
2,063,034
2,519,093
2,037,998
1,226,765
Total assets
0
19,045,043
17,060,117
17,675,357
16,132,236
Total liabilities
0
18,179,270
16,280,054
17,258,211
15,147,174
Total equity
0
865,773
780,063
417,146
985,062

P&L

Year20252024202320222021
Total operating income
37,005,761
33,684,256
30,969,913
29,648,534
25,275,735
Total operating costs
33,001,087
30,964,706
27,717,509
27,352,848
23,759,864
Operating result
4,004,675
2,719,549
3,252,403
2,295,686
1,515,871
Financial income/costs
-26,560
-73,758
-22,798
318,364
62,546
Profit before tax
3,978,114
2,645,791
3,229,605
2,614,050
1,578,417
Total tax & extraordinary income/cost
896,792
582,757
710,512
576,052
351,652
Annual Total Result
3,081,322
2,063,034
2,519,093
2,037,998
1,226,765

Balance overview

Year20252024202320222021
Total fixed assets
0
8,043,735
8,404,396
8,856,966
8,158,823
Total current assets
0
11,001,308
8,655,721
8,818,391
7,973,413
Total assets
0
19,045,043
17,060,117
17,675,357
16,132,236
Short term debt
0
17,936,800
15,984,088
17,258,211
14,997,574
Long term debt
0
242,470
295,966
0
149,600
Total liabilities
0
18,179,270
16,280,054
17,258,211
15,147,174
Contributed capital
0
30,000
30,000
30,000
30,000
Retained earnings
0
835,773
750,063
387,146
955,062
Total equity
0
865,773
780,063
417,146
985,062
Total equity and liabilities
0
19,045,043
17,060,117
17,675,357
16,132,237

Classification

21st company classification
BETA
Small company
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods